Group items tagged

Market Overview: Next-generation antibody therapeutics includes the use of new improvised therapeutic antibody to form innovative medicines for treating various diseases. Next-generation antibody therapeutics is developed clinically by pharmaceutical and biotechnology companies for several diseases. The Next Generation Antibody Therapeutics Market size was worth $ XX million in 2018 and is forecasted to reach $ XX million by 2026, expected to grow at a high CAGR during the forecast period 2019-2026. Market Dynamics: The Next Generation Antibody Therapeutics Market is growing due to several factors such as rising incidence of chronic diseases, increasing emergence of antibody technology, new drug discovery, large number of government initiatives, and growing research and development activities for new therapies. Rising prevalence of chronic disease such as cancer, asthma, diabetes and COPD are boosting the growth of the next generation antibody therapeutics market. For instance, according to National Cancer Institute in 2018, in United States, an estimated 1,735,350 new cases of cancer will be diagnosed and 609,640 people will die from the disease. The development of next-generation monoclonal antibodies has expanded beyond oncology into all therapeutic areas. For instance, ADCs were initially focused primarily on cancer, but Genentech has applied to infectious diseases, leading to the discovery and development of THIOMAB antibiotic conjugates (TACs) for the treatment of methicillin-resistant Staphylococcus aureus (MRSA). The technological advancements in antibody therapeutics have led to the development of more efficient antibody therapeutics, hence, driving the growth in the next-generation antibody therapeutics market. However, stringent government regulation, high cost and time required for research and development activities are some of the factors hindering the growth for global next-generation antibody therapeutics market. Market Segmentation: Based o

The antibody production market is segmented on the basis of products, types, technologies, applications, and end users. The increasing demand for monoclonal antibodies globally and rising R&D expenditure of pharmaceutical and biotechnology companies are major factors driving this market. Moreover, emerging markets of India and China, rising demand for protein therapeutics, and increasing risk of pandemics and infectious diseases are likely to increase the demand for equipment and consumables used in antibody production. However, high cost of primary antibodies is likely to restrain the growth of this market

The antibody production market is segmented on the basis of products, types, technologies, applications, and end users. The increasing demand for monoclonal antibodies globally and rising R&D expenditure of pharmaceutical and biotechnology companies are major factors driving this market. Moreover, emerging markets of India and China, rising demand for protein therapeutics, and increasing risk of pandemics and infectious diseases are likely to increase the demand for equipment and consumables used in antibody production. However, high cost of primary antibodies is likely to restrain the growth of this market

The experts with the Main Street Dental Team want you to know that your oral health-specifically how many cavities you have-depends on many factors, including how much fluoride you receive in the form of toothpaste, mouthwash, water, food, and fluoride products applied by dental professionals.

When a man cannot obtain or maintain a proper penile erection, he thinks that it's their fault. As a result, they may hesitate to try again for physical activity. In some cases, they avoid any sexual conditions like hugging and kissing. For men, it may cause the embarrassment; it may seriously affect the self-confidence and self-personality. A variety of risk factors like unhealthy social activities like smoking, drinking behavior, vascular damage, atherosclerosis and low level of testosterone hormone is responsible for the initiation of ED in males.

The global environmental monitoring market is poised to grow at a CAGR of 7.5% during 2015-2020, and is expected to reach a value of $20.5 Billion in 2020. A number of factors such as growing global population, development of policies and initiatives aimed to reduce air, soil, and water pollution, increasing government funding towards pollution prevention and control, growing construction of environmental monitoring stations, growing initiative towards the development of environment-friendly industries, and reduction in export tariff on environmental monitoring technologies in emerging and developed markets are fuelling the growth of the global market

North America dominated the market, with the U.S. accounting for a major market share. Asia is poised to grow at the highest CAGR during the forecast period. The large share of the North American market can be attributed to factors such as rising incidences of chronic diseases, expanding biotechnology and pharmaceutical industries, government support, and the launch of new products in the region.

The featured Innovations describe a community-level partnership that used lay health advisers and a public-private initiative that leveraged community health teams to improve chronic disease care.

Nerve repair market will grow at steady CAGR. Increasing aging population, chronic diseases and awareness will be the key drivers for the global industry.